Shares of LG Energy Solution, a leading South Korean electric-vehicle battery maker, experienced a significant surge in value following the release of its preliminary third-quarter earnings forecast that surpassed market expectations.
LG Energy Solution's stock witnessed a remarkable increase of up to 8.3%, reaching 496,500 won ($369.79) during early trade on Wednesday. This surge marks the largest daily percentage gain in 20 months, outperforming the benchmark Kospi's growth of 2.5%, as reported by FactSet.
The positive market response was triggered by LG Energy Solution's announcement that it anticipates a 40% year-on-year jump in operating profit for the July-September quarter, amounting to KRW731.20 billion. This outlook significantly surpasses the market consensus forecast of KRW649.65 billion compiled by FactSet. It is important to note that the company's preliminary quarterly operating profit includes an estimated KRW215.5 billion derived from U.S. tax credits made available under the Inflation Reduction Act.
Furthermore, LG Energy Solution anticipates a 7.5% year-on-year increase in third-quarter revenue, forecasting it to reach KRW8.224 trillion.
The impressive forecast has positioned LG Energy Solution as a crucial EV battery supplier to renowned global car manufacturers, including General Motors.
In summary, LG Energy Solution's remarkable third-quarter earnings forecast has propelled its shares to soar, demonstrating the company's substantial growth potential and solidifying its position in the electric vehicle industry.
CleanCore Solutions Files for IPO
Our Latest News
Lloyds Banking Group Reports Q2 2023 Profit Below Expectations, Upgrades Guidance
Lloyds Banking Group reports Q2 profit below expectations but upgrades guidance, with an optimistic outlook for the year.
BlueScope Steel Reports 64% Drop in Full-Year Profit
BlueScope Steel reports a 64% decrease in full-year profit due to declining market prices. Despite this, the company remains committed to enhancing production a...
BioNTech's Q2 Revenue Misses Expectations, Shares Fall
Shares of BioNTech dropped as Q2 revenue falls short of expectations due to write-offs by Pfizer, leading to lower profit share. The company remains optimistic...